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Abstract 
Background: Although oral lichen planus has been classified by the World Health Organization (WHO) as a po-
tentially malignant disorder, such classification is still the target of much controversy. Aim: To evaluate the cell 
proliferation rate in oral lichen planus, comparing it to the rate observed in epithelial dysplasia and oral squamous 
cell carcinoma, aiming at indications which might indicate the potential for malignant transformation . Material 
and Methods: Twenty-four cases of each lesion were submitted to the streptoavidin-biotin and AgNOR technique 
to evaluate the immunohistochemical expression of PCNA and the mean NORs/nucleus, respectively. Results: 
Positivity for PCNA was observed in 58.33% of oral lichen planus cases, 83.33% of epithelial dysplasia cases 
and 91.67% of oral squamous cell carcinoma cases. Chi-squared test showed that the number of positive cases for 
PCNA was significantly lower in oral lichen planus than in oral squamous cell carcinoma (p<0.05). No significant 
statistical difference between oral lichen planus and epithelial dysplasia (p>0.05) and between the epithelial dys-
plasia and oral squamous cell carcinoma (p>0.05) was observed. The mean NORs/nucleus in oral lichen planus, 
epithelial dysplasia and oral squamous cell carcinoma were 1.74±0.32, 2.42±0.62 e 2.41±0.61, respectively. Va-
riance analysis (ANOVA) revealed significant statistical difference between oral lichen planus and the other studied 
lesions (p<0.05). Conclusion: Oral lichen planus cell proliferation rate was less than in oral epithelial dysplasia and 
oral squamous cell carcinoma which might explain the lower malignant transformation rate.
Key words: Oral lichen planus, epithelial dysplasia, oral squamous cell carcinoma, immunohistochemistry, Ag-
nor.
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Introduction
The evaluation of the cell proliferation rate brings im-
portant information regarding diagnosis and prognosis 
of several types of cancer. In addition, the enhancement 
of the proliferation capacity may be one of the first indi-
cators of malignant transformation, since it constitutes 
a key event for the development of cancer. Among the 
several techniques used for such evaluation, the immu-
nohistochemistry analysis of proteins expressed during 
the cell cycle, such as PCNA, and the quantative analy-
sis of NORs, through the histochemistry of AgNORs, 
deserves notability due to their easiness in execution, 
low cost and high trustworthiness.
Describe initially by Myiachi et al. (1), from serum of 
patients with systemic lupus erythematosus, PCNA 
(proliferating cell nuclear antigen) is a nuclear acid pro-
tein of 36 KDa, which works as an auxiliary protein of 
delta polymerase, associated to the DNA duplication 
and repair (2). The concentration of PCNA is variable 
during the steps of the cell cycle, being higher in late 
G1 phase, with peaks in G1/S phase, being practically 
absent in G2 and M phases (3).
The results obtained through the evaluation of the cell 
proliferation rate using PCNA are comparable to the 
traditional methods and even superior to methods such 
as flow cytometry and bromodoxiuridine incorporation. 
Several studies describe the application of monoclonal 
antibodies against PCNA, since this is a fine indicator 
of the biological behavior of some premalignant and 
malignant lesions (4).
The AgNOR techniques marks the proteins associated 
to the nucleolar organizer regions (NORs), which were 
first described by Heintz (1931) and McClintock (1934) 
(5).  NORs are loops of DNA that transcribe for ribos-
omal RNA. They are located on the short arm of chro-
mosomes 13, 14, 15, 21, and 22. Associated with these 
regions are certain acidic and argyrophilic, non-histon-
ic proteins called NOR-associated proteins. NORs can 
be demonstrated in tissue sections by staining their as-
sociated proteins with colloidal silver and these silver-
stained reaction products represent the argyrophilic nu-
cleolar organizer regions (AgNORs)(6).
According to Derenzini and Trerè (7), the higher the 
number of NORs, the lower is the duration of the cell 
cycle and the higher is the velocity of cell proliferation. 
Such relationship makes the quantative analysis of NORs 
an excellent indicator of the proliferation activity of the 
cells and a valuable diagnostic tool, since it enables the 
differentiation of benign from malignant cells and even 
predicts the prognosis of different types of cancer (8).
Therefore, the evaluation of the cell proliferation rate, 
through the immunohistochemical expression of PCNA 
and the quantative analysis of NORs may bring useful 
information regarding the malignant potential of oral 
lichen planus. This pathology, although being consid-
ered by the World Health Organization (WHO) as a po-
tentially malignant disorder (9) is still target of much 
controversy, due to the lack of clear clinical and histho-
pathological criteria for its correct diagnosis (10-12).
According to González-Moles et al. (12), most studies 
on cell proliferation in oral lichen planus have reported 
a marked increase in the proliferation rate of basal epi-
thelial cells and some authors have proposed that this 
might be an important event in the development of can-
cer in oral lichen planus.
The purpose of the present study is to evaluate the cell 
proliferation rate in oral lichen planus through the anal-
ysis of the expression of PCNA and quantative analy-
sis of NORs, comparing it with the rate observed in 
epithelial dysplasia and oral squamous cell carcinoma, 
aiming at indications which might comprove or not the 
malignant potential transformation of this disease or at 
least, help identify the cases which present the higher 
malignant transformation risk.
Material and Methods
Twenty-four cases of oral lichen planus, 24 cases of epi-
thelial dysplasia (4 mild, 12 moderate, 8 severe) and 24 
cases of oral squamous cell carcinoma obtained from 
the files of the Department of Bioscience and Oral Di-
agnosis of the São José dos Campos Dental School, São 
Paulo State University, Brazil were used in the study. 
Age and gender of patient were not considered because 
these data are not related to the increase of the risk of 
malignant transformation of oral lichen planus.
The cases of oral lichen planus were selected according 
to Eisenberg’s criteria (11). Two 3μm histological sec-
tions were cut from the paraffin-embedded blocks. One 
section was stained according to streptoavidin-biotin 
technique and the other was stained according to Ag-
NOR technique.
Immunohistochemical reaction against PCNA (PC10 
clone; dilution, 1:300) was performed in 3μm histo-
logical sections. The sections were dewaxed in xylene, 
rehydrated in graded alcohol, and rinsed in water. To 
inhibit endogenous peroxidase activity, the sections 
were treated by immersion in two changes of 6% H2O2 
in absolute methanol (5 min each change) and rinsing in 
water. For antigen retrieval, the sections were immersed 
in 10 mM sodium citrate buffer (pH 6.0) and boiled for 
15 min in a microwave oven (700 W). After washing 
with Tris buffer (pH 7.4), the slides were incubated at 
4oC for eighteen hours with monoclonal antibodies. Af-
ter incubation, immunodetection was performed with 
the LSAB Visualization System (DakoCytomation, 
Glostrup, Denmark) using 3,3’-diaminobenzidine chro-
mogen as substrate, according to the manufacturer’s 
instructions. Slides were counterstained with Mayer’s 
hematoxylin, dehydrated, and mounted in Permount@ 
(Fisher Scientific, Fair Lawn, USA).
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Paraffin-embedded epithelial hyperplasia biopsied cas-
es served as positive controls. For a negative control, 
the primary antibodies were replaced with the antibody 
diluent solution.
Regarding PCNA expression, the cases were classified 
according to the number of positively stained cells per 
1.000 counted cells in all epithelium layers (basal, inter-
mediate and superficial layers) as: positive (more than 
5% of cells were stained) and negative (less than 5% of 
cell stained).
The AgNOR technique was adapted from that described 
by Ploton et al. (13). After dewaxed in xylene, rehydrat-
ed in graded alcohol, and rinsed in water, the 3μm histo-
logical sections were immersion in acetic acid and 95% 
alcohol solution (3:1) for 5 min, rinsed three times in 
absolute alcohol and rinsed six times in water. The sec-
tions were reacted with freshly prepared silver colloidal 
solution (containing one part by volume of 2% gelatin in 
1% formic acid and two parts by volume of 50% aque-
ous silver nitrate solution) in closed recipient for 30 min 
at 45oC, ensuring a dark environment throughout the 
reaction time. The silver colloidal solution was washed 
with water at 45oC. Slides were then dehydrated, and 
mounted in Permount@ (Fisher Scientific, Fair Lawn, 
USA). The mean number of NORs was obtained by two 
calibrated examiner through the counting of the number 
of NORs at least 100 cells, using the 100x oil immersion 
objective of the light microscope.
The immunohistochemical expression of PCNA was 
analysis by Chi-squared test, while the mean number 
of NORs per cell in each lesion was analyzed statisti-
cally by analysis of variance (ANOVA) and by Tukey s´ 
Test. Values of p≤0.05 were considered as statistically 
significant.
Results
The positivity for PCNA was observed in 58.33% of the 
oral lichen planus cases, 83.33% of the epithelial dyspla-
sia cases and 91.67% of the oral squamous cell carcino-
ma. In cases with elevated percentage of positive cells 
for PCNA (more than 50% of cell stained), the involve-
ment of the all epithelium layers (basal, intermediate 
and superficial layers) can be observed, independently 
of the studied lesions (Fig. 1).
Chi-squared test showed that the number of positive 
cases for PCNA was significantly lower in oral lichen 
planus than in oral squamous cell carcinoma (p<0.05). 
No significant statistical difference between oral lichen 
planus and epithelial dysplasia (p>0.05) and between 
the epithelial dysplasia and oral squamous cell carci-
noma (p>0.05) was observed. The grade of epithelial 
dysplasia did not influence in the results.
The mean of NORs/nucleus in oral lichen planus, in 
epithelial dysplasia and oral squamous cell carcinoma 
were 1.74±0.32, 2.42±0.62 e 2.41±0.61. The analysis of 
variance (ANOVA) revealed significant statistical dif-
Fig. 1. Comparison of number of positive and negative cases for PCNA in three studied lesions.
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ference between oral lichen planus and the other studied 
lesions (p<0.05). However, there was no significant sta-
tistical difference between epithelial dysplasia and oral 
squamous cell carcinoma (p>0.05).
In oral lichen planus and in epithelial dysplasia, the 
NORs presented themselves with round and regular 
contours. However, in oral lichen planus, they exhibit 
less size variation and greater volume than in epithe-
lial dysplasia. On the other hand, in oral squamous cell 
carcinoma NORs presented themselves with irregular 
shape and great size variation.
Discussion
The results obtained from the present study showed that 
the number of positive case for PCNA in oral lichen 
planus is lower than in epithelial dysplasia, although 
had no significant statistical difference between these 
two lesions, and oral squamous cell carcinoma. This 
fact suggests that, in general, the cell proliferation rate 
in oral lichen planus is lower than the other studied le-
sions. Therefore, oral lichen planus has a lower possibil-
ity to accumulate genetic mutations than the epithelial 
dysplasia and oral squamous cell carcinoma and, conse-
quently, a lower possibility to suffer malignant transfor-
mation. This is because the higher the cell proliferation 
rate, the higher the risk of cells suffering mutations dur-
ing mitosis, which could result in malignant phenotype. 
In context, the cases of oral lichen planus with elevated 
percentage of positive cells for PCNA (more than 50% 
of cell stained) can have a higher malignant transfor-
mation risk. In addition, in these cases, the presence of 
the positive cell for PCNA in superficial layer of epithe-
lium suggests possible alterations in cell differentiation 
mechanisms, step essential to the malignant transfor-
mation of epithelium.
According to Lee et al. (14), the expression of PCNA in 
oral lichen planus is similar to hyperkeratosis, but supe-
rior to normal mucosa and inferior to epithelial dyspla-
sia and oral squamous cell carcinoma, being in accord-
ance to the results obtained in these studies. However, 
for Da Silva Fonseca and Do Carmo (15), the higher cell 
proliferation rate in oral lichen planus than in hyperk-
eratosis and normal mucosa makes it more susceptible 
to the action of carcinogens. González-Moles et al. (16) 
also believe that although oral lichen planus does not 
present a higher susceptibility to apoptosis in compari-
son to normal mucosa, interruptions of the cell cycle 
and enhancement of cell proliferation rate may create a 
favorable substract to malignant transformation.
Such findings might explain why the World Health Or-
ganization (WHO) although considers the oral lichen 
planus as a potentially malignant disease, states that its 
malignant transformation potential is lower than in leu-
koplakia (with epithelial dysplasia) and erythroplakia 
(9). However, this position is still target of much con-
troversy, since several authors believe that many of the 
cases of oral lichen planus with malignant transforma-
tion described in the literature are in fact consequences 
of flaws in the diagnosis of the disease, since, in some 
cases, sutil dysplastic alterations may have been over-
looked in the initial histopathological exam (10-12).
In this case, not only the quantative but also the quali-
tative analysis of NORs has shown to be effective in 
distinguishing oral lichen planus from the other stud-
ied lesions. In fact, the mean NORs/nucleus was con-
siderably lower in oral lichen planus than in epithelial 
dysplasia and in squamous cell carcinoma. In addition, 
NORs morphology in oral lichen planus and in epithe-
lial dysplasia was significantly different than in oral sq-
uamous cell carcinoma, which means that there were 
significant morphological differences in the potentially 
malignant diseases regarding oral squamous cell carci-
noma, a eminent malignant disease. 
According to Xie et al. (17), the quantitative analysis of 
NORs may help distinguish a normal epithelium from 
epithelial dysplasia and oral squamous cell carcinoma. 
In fact, for Ray et al. (18), the quantative analysis of 
NORs is a useful tool for the definitive diagnosis of epi-
thelial dysplasia. However, according to Elangovan et 
al. (2008) (6), the quantative analysis of NORs is pro-
portional to the cell proliferation rate and not necessar-
ily indicates the malignant transformation potential of 
a specific lesion, but the morphologic characteristic of 
NORs may be an important tool in the attempt of dif-
ferencing hyperplasic, pre-malignant and malignant le-
sions.
In summary, the results observed in the present study 
corroborate Cano Montoya et al. (19). For them, the Ag-
NOR technique may be used as a complement in routine 
histopathological study, especially in lesions with po-
tential of malignant transformation such as oral lichen 
planus and epithelial dysplasia, since numerical and 
morphological variations of NORs may indicate impor-
tant cellular alterations, minimizing possible diagnostic 
mistakes. In addition, AgNOR technique is easy and 
quite economical in comparison to the immunohisto-
chemistry and molecular biology techniques.
Although the obtained results may not confirm the ma-
lignant transformation potential of oral lichen planus, 
the fact that its cell proliferation rate is inferior than epi-
thelial dysplasia’s and oral squamous cell carcinoma’s 
might explain why its malignant transformation po-
tential is lower than epithelial dysplasia’s. In addition, 
the quantitative and qualitative analysis of NORs has 
shown to be useful in distinguishing potentially malig-
nant disorder from oral squamous cell carcinoma per se, 
assisting the evaluation of oral lichen planus cases that 
present higher risk of malignant transformation.
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